278 related articles for article (PubMed ID: 21156017)
1. Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma.
Staehler M; Haseke N; Nuhn P; Tüllmann C; Karl A; Siebels M; Stief CG; Wowra B; Muacevic A
BJU Int; 2011 Sep; 108(5):673-8. PubMed ID: 21156017
[TBL] [Abstract][Full Text] [Related]
2. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery for spinal metastases with or without separation surgery.
Bate BG; Khan NR; Kimball BY; Gabrick K; Weaver J
J Neurosurg Spine; 2015 Apr; 22(4):409-15. PubMed ID: 25635638
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery for intraventricular brain metastases.
Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.
Muacevic A; Kreth FW; Mack A; Tonn JC; Wowra B
Minim Invasive Neurosurg; 2004 Aug; 47(4):203-8. PubMed ID: 15346315
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
[TBL] [Abstract][Full Text] [Related]
8. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
[TBL] [Abstract][Full Text] [Related]
9. Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma.
Barata PC; Mendiratta P; Kotecha R; Gopalakrishnan D; Juloori A; Chao ST; Koshkin V; Ornstein M; Gilligan TD; Wood LS; Rini BI; Angelov L; Garcia JA
Clin Genitourin Cancer; 2018 Oct; 16(5):413-419.e1. PubMed ID: 30172552
[TBL] [Abstract][Full Text] [Related]
10. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
11. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.
Kano H; Iyer A; Kondziolka D; Niranjan A; Flickinger JC; Lunsford LD
Neurosurgery; 2011 Dec; 69(6):1232-9. PubMed ID: 21716155
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma.
Gerszten PC; Burton SA; Ozhasoglu C; Vogel WJ; Welch WC; Baar J; Friedland DM
J Neurosurg Spine; 2005 Oct; 3(4):288-95. PubMed ID: 16266070
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
[TBL] [Abstract][Full Text] [Related]
14. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases.
Ahluwalia MS; Chao ST; Parsons MW; Suh JH; Wang D; Mikkelsen T; Brewer CJ; Smolenski KN; Schilero C; Rump M; Elson P; Angelov L; Barnett GH; Vogelbaum MA; Weil RJ; Peereboom DM
J Neurooncol; 2015 Sep; 124(3):485-91. PubMed ID: 26245136
[TBL] [Abstract][Full Text] [Related]
16. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.
Vickers MM; Al-Harbi H; Choueiri TK; Kollmannsberger C; North S; MacKenzie M; Knox JJ; Rini BI; Heng DY
Clin Genitourin Cancer; 2013 Sep; 11(3):311-5. PubMed ID: 23684422
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study.
Sohn S; Chung CK; Sohn MJ; Chang UK; Kim SH; Kim J; Park E
J Neurooncol; 2014 Aug; 119(1):121-8. PubMed ID: 24792488
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.
Marko NF; Angelov L; Toms SA; Suh JH; Chao ST; Vogelbaum MA; Barnett GH; Weil RJ
World Neurosurg; 2010 Mar; 73(3):186-93; discussion e29. PubMed ID: 20860956
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
